Emily’s Entourage is an innovative 501(c)3 that accelerates research for people in the final 10% of the cystic fibrosis (CF) population that do not benefit from existing CFTR modulators. Since 2011, Emily’s Entourage has awarded millions of dollars in research grants, launched a now-acquired CF gene therapy company, developed a patient registry and clinical trial matchmaking program to accelerate trial recruitment, and led worldwide efforts to drive high-impact research and drug development.
